Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Talcid vs Famotidine vs Placebo for Acute Heartburn
NCT01928888Phase 4Completed
- Sponsor
- Bayer
- Start
- May 2003
- Primary completion
- Feb 2004
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Talcid in gastroesophageal reflux disease (GERD) (6 arms), sponsored by Bayer. Primary endpoint: Total heartburn relief over 0-60 min. Started May 2003; status: completed.
02
Drugs
Talcid
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT01928888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01928888.